No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
REGN241213C752500
- 2.68
- -25.22-90.39%
15min DelayClose Dec 12 16:00 ET
5.70High2.68Low
5.70Open27.90Pre Close2 Volume5 Open Interest752.50Strike Price838.00Turnover43.08%IV1.92%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry2.68Extrinsic Value100Contract SizeAmericanOptions Type0.2438Delta0.0195Gamma322.16Leverage Ratio-2.7703Theta0.0045Rho78.54Eff Leverage0.1173Vega
Intraday
- 5D
- Daily
News
BofA Restarts Coverage of 11 Large-cap Biopharmas
Piper Sandler Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,195
Regeneron Pharmaceuticals (REGN): Sales Struggles and Future Prospects
B of A Securities Reinstates Underperform on Regeneron Pharmaceuticals, Announces $565 Price Target
Regeneron Pharmaceuticals Analyst Ratings
Regeneron Presents New And Updated Data For Odronextamab At ASH Annual Meeting